Expression and Mutation Statuses of Epidermal Growth Factor Receptor in Thymic Epithelial Tumors

Abstract

Although EGFR mutation at the tyrosine kinase domain is unlikely to be a therapeutic target for thymoma, the information about EGFR expression would contribute to the further identification of the therapeutic target for advanced thymomas.